Pyxis Oncology, Inc.
PYXS
$3.38
-$0.51-13.11%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 33.00M | 41.02M | 66.86M | 76.26M | 88.94M |
| Total Receivables | -- | -- | 700.00K | -- | 3.00M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.27M | 3.08M | 586.00K | 5.35M | 6.54M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.47M | 1.47M | 3.96M | 1.47M | 1.47M |
| Total Current Assets | 36.73M | 45.57M | 72.11M | 83.07M | 99.96M |
|
|
|||||
| Total Current Assets | 36.73M | 45.57M | 72.11M | 83.07M | 99.96M |
| Net Property, Plant & Equipment | 18.19M | 18.73M | 19.42M | 20.10M | 20.77M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | 0.00 | 2.43M | 2.49M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 54.92M | 64.30M | 91.52M | 105.60M | 123.22M |
|
|
|||||
| Total Accounts Payable | 3.27M | 4.99M | 10.89M | 9.76M | 9.41M |
| Total Accrued Expenses | 12.38M | 9.79M | 8.12M | 8.00M | 6.70M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.82M | 1.76M | 1.69M | 1.63M | 1.57M |
| Total Finance Division Other Current Liabilities | 10.00M | -- | 431.00K | -- | -- |
| Total Other Current Liabilities | 10.00M | -- | 431.00K | -- | -- |
| Total Current Liabilities | 27.47M | 16.53M | 21.13M | 19.38M | 17.68M |
|
|
|||||
| Total Current Liabilities | 27.47M | 16.53M | 21.13M | 19.38M | 17.68M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 16.01M | 16.50M | 16.98M | 17.44M | 17.89M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 43.48M | 33.03M | 38.11M | 36.83M | 35.57M |
|
|
|||||
| Common Stock & APIC | 503.24M | 497.72M | 496.53M | 493.78M | 490.72M |
| Retained Earnings | -491.80M | -466.45M | -443.18M | -425.07M | -403.07M |
| Treasury Stock & Other | -4.00K | -- | 53.00K | 69.00K | -5.00K |
| Total Common Equity | 11.44M | 31.27M | 53.41M | 68.78M | 87.64M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.44M | 31.27M | 53.41M | 68.78M | 87.64M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.44M | 31.27M | 53.41M | 68.78M | 87.64M |
|
|
|||||